Sunnyvale, California-based Gener8 LLC has acquired RND Group, a 25-year-old software development firm headquartered in Indianapolis, the companies announced this week.
Financial terms of the deal were not disclosed.
RND Group, which has nearly 80 employees, including 40 or so software developers, specializes in FDA-regulated software for medical devices. It is based at 5975 Castle Creek Parkway N. Drive.
Gener8, founded in 2002, is a provider of turnkey design and manufacturing services specializing in high-complexity products, primarily for medical device and diagnostics applications. Gener8 is owned by Sverica Capital Management LP
“RND is a world-class medical software development operation with a blue-chip customer base and a unique set of capabilities,” said Jerry Jurkiewicz, CEO of Gener8, in written remarks. “We have already partnered on several programs, and the value proposition of the combination has strongly resonated with customers.”
With the acquisition, Gener8 adds software development capabilities such as cloud solutions, verification and validation, and quality system compliance, among others. Gener8 says the company has a library of protocols that speed up the development process by leveraging pre-built core functionality.
“We are excited to join Jerry and the rest of the Gener8 team. From our early interactions it was clear there would be a great fit between our companies, and even more importantly, that bringing our capabilities together under one roof would be a real winner for customers,” said Tim DeFrench, founder and president of RND.
Gener8 says the acquisition allows it to extend its services “off-instrument” to the related software.